Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Current assets
Cash and cash equivalents	$ 119,818	$ 85,947
Short-term investments		29
Research and development tax credits receivable	578	290
Prepaid expenses	1,845	1,398
Other receivables	258	387
Total current assets	122,499	88,051
Operating lease right-of-use assets (note 3)	524
Property and equipment (note 4)	405	30
Total assets	123,428	88,081
Current liabilities
Accounts payable and accrued liabilities (note 5)	7,997	4,477
Current portion of operating lease liabilities (note 3)	330
Income taxes payable		56
Total current liabilities	8,327	4,533
Operating lease liabilities (note 3)	184
Total liabilities	8,511	4,533
Convertible Preferred Shares (notes 1 and 6)
Convertible preferred shares		138,758
Shareholders’ Equity (Deficit) (notes 1 and 7)
Common shares, no par value, unlimited shares authorized, 24,505,748 shares issued and outstanding as of December 31, 2019, 596,787 shares issued and outstanding as of December 31, 2018	226,245	2,039
Additional paid-in capital	3,805	2,655
Cumulative translation adjustment	(1,634)	(1,634)
Accumulated deficit	(113,499)	(58,270)
Total shareholders’ equity (deficit)	114,917	(55,210)
Total liabilities, convertible preferred shares and shareholders’ equity (deficit)	$ 123,428	$ 88,081